Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

March
02
2022

Sensus Healthcare Sells its Sculptura™ Assets to Empyrean Medical Systems for $15 Million in Cash

Sale permits Sensus to focus on the core dermatology market while providing capital for channel expansion BOCA RATON, Fla., March 02, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly…

February
16
2022

Full Body Skin Cancer Screening Appointments

While many people enjoy spending time outdoors, not enough people truly understand how damaging the sun’s UV rays can be to the skin. Overexposure to UV rays is the number one cause of skin cancer,…

February
16
2022

Report on Cellulite reduction treatments through Dermoelectroporation

Dr. Suneil Jain, N.M.D. Scottsdale Natural Medicine and Healing Clinic, LLC, 8390 E. Via de Ventura Blvd. Suite F-111 Scottsdale, AZ 85258   Preliminary Study To evaluate the safety, tolerability and effectiveness of transdermal delivery…

February
16
2022

Improvement of Facial Rhytids through a Novel Transdermal Drug Delivery System

Jaggy Rao, MD* , MD Division of Dermatology, University of Alberta Edmonton, Alberta, Canada   Preliminary Study To evaluate the safety, tolerability and effectiveness of transdermal Hyaluronic Acid (HA) delivery using Dermelectroporation® Study Design 10…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy